If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

Osteoarthritis (OA) is often called the ‘wear and tear’ arthritis that mostly comes with aging. Rheumatoid arthritis (RA) however tells a very different story. RA is a chronic autoimmune condition ...

A new treatment could soon offer hope to some breast cancer patients in the UAE whose disease develops resistance to hormone therapy. The Emirates Drug Establishment (EDE) has approved AstraZeneca's ...

US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic ...

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

PTSD is not a battlefield cliché or a character flaw, but a survivable injury of the nervous system that demands early recognition, competent treatment, and a culture willing to stop letting warriors ...

AstraZeneca's drug Truqap in combination with two other medications secured approval for the treatment of a form of advanced prostate cancer by the Food and Drug Administration. Approval was based on ...

REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today ...

Objectives While extracorporeal shockwave therapy (ESWT) may be an efficacious adjunctive treatment option for musculoskeletal injuries, current research is limited by significant heterogeneity within ...